Frazier Life Sciences
Biotech Investor · 6 portfolio companies
Portfolio
6
Combined Value
$110.5M
Focus Areas
7
Top Stage
Pre-clinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| enGene | $110.5M |
| Radionetics Oncology | — |
| Eccogene | — |
| Atom Bioscience | — |
| Hillstar Bio | — |
| Sonoma Biotherapeutics | — |